跳至主要内容
临床试验/IRCT20180519039715N3
IRCT20180519039715N3招募中1 期

Determination of effective therapeutic regimen via Levamisole in controlling the idiopathic nephrotic syndrome relapse among children

Kermanshah University of Medical Sciences0 个研究点目标入组 188 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
188

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 15 years(—)
性别
All

入选标准

  • Patients affliction with steroid-dependent idiopathic nephrotic syndrome or with high number of relapses
  • 2-15 years old
  • non-use of steroid supplementation

排除标准

  • Patient treatment with Levamisole for less than 4 months (the minimum follow-up period)
  • the children’s affliction with any chronic disease other than nephrotic syndrome

研究者

相似试验